Optimising cardioprotection during myocardial ischaemia: targeting potential intracellular pathways with glucagon-like peptide-1.

Optimising cardioprotection during myocardial ischaemia: targeting potential intracellular pathways with glucagon-like peptide-1.
复制标题

DOI:
10.1186/1475-2840-13-12
复制
发表时间:
2014-01-11
影响因子:
9.3
通讯作者:
Dutka DP
Dutka DP
中科院分区:
医学1区
文献类型:
--
作者:
Clarke SJ;McCormick LM;Dutka DP

文献摘要

参考文献

被引文献

相似文献

冠心病和 2 型糖尿病都是与心肌梗死 (MI) 风险增加相关的主要全球健康负担。心肌梗死后,缺血再灌注损伤(IRI)仍然是细胞水平上心肌损伤的重要原因。研究重点是确定一种策略或干预措施,以最大限度地减少 IRI,从而优化再灌注治疗,从而提供卓越的临床结果。肠促胰岛素激素胰高血糖素样肽-1 已成为治疗 2 型糖尿病的基础,也具有预防 IRI 的潜力。我们解释了 IRI 涉及的生理学和细胞过程,以及 GLP-1 激活的细胞内途径,GLP-1 可以拦截 IRI 并提供心脏保护作用。该综述还审查了 GLP-1 在心脏保护方面的当前临床前和临床证据以及未来的研究方向,因为我们正在寻找有效的辅助治疗以尽量减少 IRI。
Coronary heart disease and type-2 diabetes are both major global health burdens associated with an increased risk of myocardial infarction (MI). Following MI, ischaemia-reperfusion injury (IRI) remains a significant contributor to myocardial injury at the cellular level. Research has focussed on identifying a strategy or intervention to minimise IRI to optimise reperfusion therapy, with the aim of delivering a superior clinical outcome. The incretin hormone glucagon-like peptide-1, already an established basis for the treatment of type-2 diabetes, also has the potential to protect against IRI. We explain the physiology and cellular processes involved in IRI, and the intracellular pathways activated by GLP-1, which could intercept IRI and deliver cardioprotection. The review also examines the current preclinical and clinical evidence for GLP-1 in cardioprotection and future directions for research as we look for an effective adjunctive treatment to minimise IRI.
DOI: 10.1007/bf00762735
发表时间: 1994-10-01
影响因子: 3
作者:
BERNARDI, P;BROEKEMEIER, KM;PFEIFFER, DR
通讯作者: PFEIFFER, DR
DOI: 10.1042/bst0380841
发表时间: 2010-08-01
影响因子: 3.9
作者:
Halestrap, Andrew P.
通讯作者: Halestrap, Andrew P.
DOI: 10.1016/j.abb.2008.08.001
发表时间: 2008-10-15
影响因子: 3.9
作者:
Green, Brian D.;Hand, Katharine V.;Grieve, David J.
通讯作者: Grieve, David J.
DOI: 10.1161/circresaha.107.167072
发表时间: 2008-05-09
影响因子: 20.1
作者:
Clarke, Samantha J.;Khaliulin, Igor;Das, Manika;Parker, Joanne E.;Heesom, Kate J.;Halestrap, Andrew P.
通讯作者: Halestrap, Andrew P.
DOI: 10.1016/j.yjmcc.2004.12.001
发表时间: 2005-02-01
影响因子: 5
作者:
Argaud, Laurent;Gateau-Roesch, Odile;Ovize, Michel
通讯作者: Ovize, Michel